Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thank you for heads up, on merger, $OPGN
OPGN 5.5m OS btw.
OPGN $3.90 now Dipped to $2.5 today
OPGN $3.57 merger closing March 10th after they get shareholder approval. Corona virus merger.
OpGen filed and furnished to its stockholders a proxy statement/prospectus and a notice of special meeting of OpGen stockholders to be held on March 10, 2020 to approve the business combination with Curetis. On the same day at 1:00pm CET, Curetis will host its extraordinary shareholder
meeting with the objective of seeking approval from its shareholders for the planned business combination with OpGen.
Curetis GmbH’s subsidiary Ares Genetics’ collaboration with BGI Group to offer Next-Generation Sequencing (NGS) and PCR-based Coronavirus (2019-nCoV) testing in Europe.•Curetis GmbH and Quaphaco entered into an exclusive distribution partnership for Vietnam for an initial term of three years with Quaphaco committing to a minimum purchase.
OpGen, Inc. (Nasdaq: OPGN) reported an update on the business of Curetis GmbH (“Curetis”), the other party to the planned business combination with OpGen.
PTON $28. Nobody is going to want to go work out at the gym as the virus spreads. Have to exercise at home.
Amazing call Rain! Any others?
CODX $10.8
CODX $10.21
Great call Rain.
Wish I would have, should have bought.
CODX $9.09
CODX $9.09
CODX $8.37
CODX $7.6
CODX $6.65
CODX $6.07
CODX $5.67
CODX $5.24
The Rainmaker Wednesday, 01/29/20 02:25:31 PM
Re: None 0
Post #
49524
of 49533
CODX $2.5 Co-Diagnostics finalizes its own unique Coronavirus detection test http://tinyurl.com/vm6e2gj via
@proactive_uk
PENN........rocking on, in a “gamely” manner......nice movement the last few weeks.
DEACW 6 DEAC $18.20
DEACW $5.45 DEAC $17
CODX hit $4.24
CODX $3.92 news
CODX HUGE week next week! Do some DD!
** FUNN **
I have been invested in this stock since 2017.
Bought at $.015 and kept on buying.
The reason FUNN only has 4 Locations is because the CEO applied to uplist from the Pinks to the otcmarkets two Years ago.
One big problem.....3 Years of back Audits had to be done.
This instantly pissed off the Auditor [RBSM] and they prolonged the 3 Year Audit for Two Years.
2018 Audit is now done plus the 2019 Un-Audited Financials are done.
Quarter 1 of 2020 Un-Audited is also done as Fiscal Year ends for this company on June 30th of every Year.
This company is Amfil Technologies, Inc. and they have 3 Subsidiaries.
1.Snakes and Lattes.....[4 Board Game Café’s plus two more locations announced].
2.Gro-3 division for growing 100% Organic Marijuana plus used with infused THC beverages:
https://www.globenewswire.com/news-release/2018/11/05/1645181/0/en/Amfil-Technologies-Inc-s-GRO3-Division-Enters-Into-Exclusive-Agreement-with-Cannabis-Infused-Beverage-Maker-Kalvara-With-LOI-to-Provide-an-Estimated-8-EcoPro3-Antimicrobial-Technol.html
3.Inter-loc Kings for Landscaping and Snow Plow Removal[Canada only].
Recently .....Snakes and Lattes[FUNN Ticker]announced the purchase of Starlit Citadel to help with online distribution for popular Board Games.
Starlight is the second biggest distributor of Board Games right behind the #1 distributor in Canada = Snakes and Lattes.
https://www.globenewswire.com/news-release/2019/12/12/1959864/0/en/Amfil-Technologies-Inc-Through-Its-Subsidiary-Snakes-Lattes-Inc-Acquires-Fulfillment-Operations-of-Starlit-Citadel-the-Second-Largest-Board-Game-Fulfillment-House-in-Canada.html
Two more Café’s coming to Snakes and Lattes in 2020:
https://www.globenewswire.com/news-release/2019/08/27/1906850/0/en/Amfil-Technologies-Inc-Announces-Acquisition-of-Existing-Board-Game-Bar-Cafe-in-Guelph-Ontario.html
https://www.globenewswire.com/news-release/2019/05/13/1822494/0/en/Amfil-Technologies-Inc-Signs-Lease-for-New-Snakes-Lattes-Venue-in-Tucson-AZ-Announces-Shipping-Date-for-Kill-the-Unicorns-and-Provides-Accounting-and-Audit-Update.html
Snakes and Lattes only build their Café’s close to Major Universities because College Students love the Camaraderie when playing these Board Games.
Snakes and Lattes also owns their own Game board Publisher called “Morning” in the country of France:
https://www.globenewswire.com/news-release/2018/05/29/1513112/0/en/Amfil-Technologies-Inc-Acquires-Morning-Board-Game-Publishing-Distribution-Company-From-France-in-an-All-Cash-Deal.html
Once FUNN becomes uplisted to the OTCQB they will change their Corporate name to reflect Snakes and Lattes.
Then following that......Gro-3 and Inter-Loc Kings will be spun off as a separate OTCQB listed stock and will give Shares in the form of a Dividend to all present FUNN shareholders.
Recently announced:
https://www.otcmarkets.com/stock/FUNN/news/Amfil-Technologies-Inc-Inks-Deal-To-Bring-Ten-New-Snakes--Lattes-Locations-To-The-USA?id=251826
CODX $2.5 Co-Diagnostics finalizes its own unique Coronavirus detection test http://tinyurl.com/vm6e2gj via
@proactive_uk
DEAC - Thanks Rain.......very cool..,...the world is finding out about us more and more each day.
These type articles by a respected source speak volumes about how big we’re going to be. I’m pretty excited about this one.
DEAC-Draftkings ... Front page of Barron's : https://www.barrons.com/articles/sports-gambling-will-be-a-huge-opportunity-bet-on-these-stocks-51579915327?mod=hp_HERO?mod=article_signInButton
KNOS...0030...their air filter kills cornoavirus among other small microbes...not your typical hepa filter
$$ FCEL is a fantastic Pick.
Main Energy Source of the Future!!
$ FUNN *
Amfil Technologies Inc. Inks Deal To Bring Ten New Snakes & Lattes Locations To The USA:
https://www.otcmarkets.com/stock/FUNN/news/Amfil-Technologies-Inc-Inks-Deal-To-Bring-Ten-New-Snakes--Lattes-Locations-To-The-USA?id=251681
Amfil Technologies Inc. (OTC: FUNN) is pleased to announce that the company has entered into an agreement to aggressively expand the Snakes & Lattes subsidiarys brick and mortar locations in the USA. A group of professionals and investors, along with the existing USA Expansion Team members, will spearhead the rollout of the additional USA locations. It is expected that these new locations will be built at a much faster rate than seen to date, some being worked on simultaneously using the guidelines and model already established by Snakes & Lattes Inc.
The initial agreement is for the opening of ten (10) additional corporate owned locations in the USA, effectively tripling the total number of worldwide corporate owned locations. The expansion team is confident in the success of the proposed openings and have agreed to forfeit any compensation until the first milestone of four (4) new locations in the USA have opened. Management and the company is also very confident in the USA Expansion Teams abilities in that upon this first milestone completion of four (4) new corporate owned locations, Roger Mortimer has agreed to pledge a portion of his own preferred shares to compensate the group for their efforts to that point to help minimize share dilution for the benefit of all shareholders and the company.
This agreement is independent and will not affect the Tempe, AZ location which is already open as well as the Tucson, AZ location which is in the build out process. The group has committed to the simultaneous construction of numerous cafes, and they are confident they will be capable of maintaining the high standard customers of Snakes and Lattes Inc. are accustomed to. The accelerated expansion will lead to a significant increase in the companys growth rate, exceeding anything the company and shareholders have witnessed previously.
The company is also pleased to announce the recent addition of Mr. Rogen K. Chhabra to the USA Expansion Team. Mr. Chhabra was born in Seattle, WA, graduated in 1995 Cum Laude from Millsaps College, B.S. in Math and graduated in 1998 Magna Cum Laude from the Mississippi College School of Law. Mr. Chhabra is a founding partner of Chhabra & Gibbs P.A. Attorneys at Law and has since grown the firm with his partner to over thirty (30) lawyers and staff. Mr. Chhabra has written many articles and given many lectures in the field of law but also has extensive experience in construction, buildouts and renovations. Mr. Chhabra, in agreement with his law firm partner, has decided to come on board the USA Expansion Team full time while his business partner continues running the law firm they founded.
I am very pleased to come on board the USA Expansion Team full time, states Rogen Chhabra. I believe I can add a lot of value and contribute in a very impactful way with this opportunity to really ramp up and push the expansion initiative to the next level. We are excited to get our first goal of ten (10) new corporate owned locations in the USA up and running in short order and will look to extend and expand our agreement to many more locations once the first starting goal has been attained.
If shareholders or others are interested in learning more about the USA expansion, or if there is an opportunity or ideal location they are aware of and feel the company should be looking at, please send an email to usaexpansion@snakesandlattes.com.
Shareholders can expect timely and continued updates on the progress being made by the USA Expansion Team going forward as the information becomes available.
For further updates from Snakes & Lattes and its parent company, Amfil Technologies Inc., please follow us on Twitter @AmfilTech
For more information regarding the company, and its related subsidiaries please visit the following websites:
Amfil Technologies Inc. www.amfiltech.com/
Snakes & Lattes Inc. www.snakesandlattes.com/
Morning (Snakes & Lattes Publishing SAS) https://www.morning.us/
GRO3 Joint Venture http://gro3systems.com/
Interloc-Kings Inc. http://www.interloc-kings.com/
______________________________________________
Note:
Investors in Snakes and Lattes[FUNN] will indeed be..... deeply rewarded.
Now.....Institutional Investors will once again be drawn to the FUNN attraction = Snakes and Lattes.
I predict FUNN could be $.25 by February of 2020.
$RAFA Cannabis NEWS* Rafarma [OTC RAFA] Closes "Exclusive" Joint Venture Contract with Thailand Cannabis Partner
https://finance.yahoo.com/news/rafarma-closes-exclusive-joint-venture-134510427.html
Here is another SPAC play with warrants!
FPAC and FPAC/WS
https://www.wsj.com/articles/far-point-acquisition-nears-deal-to-buy-global-blue-from-silver-lake-11579170605
Yes today was the first day for the deac options. I still think the deacw warrants with a six year expiration are a much more attractive value proposition. Glad you joined us in deac deacw
DEAC - Good stuff, Rain......
I took advantage of a few February 21 - $15 call options today.
Glad options are now available.
$$ DEAC $$
DEAC Traded over $36 million dollars today. Obvious loading by larger institutional investors..Launching DEAC stock options today opens up more hedging options allowing more aggressive buying
FCEL $2.20 moving up again heading into next weeks earnings report and CC
XXII Panacea Life Sciences, Inc Closes Series A Investment Round with 22nd Century Group to Expand CBD Operations
Panacea Life Sciences Logo
Panacea Life Sciences Logo
Investment bolsters expansion of Panacea’s CBD manufacturing capabilities and leverages 22nd Century's strengths in packaged-goods and FDA-regulatory affairs.
22nd Century’s investment will allow us to continue to scale our business – including the acceleration of our online and retail sales.”— Leslie Buttorff (CEO of Panacea Life Sciences, Inc.)
GOLDEN, COLORADO, UNITED STATES, January 15, 2020 /EINPresswire.com/ -- Panacea Life Sciences, Inc. (Panacea), a rapidly-growing, vertically-integrated, consumer-facing company operating exclusively in the legal, hemp-derived, CBD product space has received Series A Funding from 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis plant research. 22nd Century’s investments in Panacea over the next twelve to eighteen months are expected to total $24 million in a combination of cash and 22nd Century stock in exchange for Panacea issued convertible debt and preferred equity. 22nd Century has also received a warrant to purchase additional preferred stock of Panacea, which upon full exercise will provide 22nd Century with a controlling equity position in Panacea.
“We are pleased to enter into this long-term, strategic partnership with 22nd Century,” said Leslie Buttorff, Chief Executive Officer of Panacea Life Sciences, Inc. “With a strong team and seed-to-sale operations in place, Panacea is on track to deliver sales growth of over 1,000 percent in 2019, with gross margins over 50%. Our success has been possible because of our focus from day one on producing and marketing the highest-quality, hemp-derived, premium CBD products.
“Our supply chain is complete with track-and-trace capabilities and stringent quality control and testing at every step, from our plant nursery and farm in Colorado’s western slope to our comprehensive extraction, distillation, testing and manufacturing operations located in Golden, Colorado. With state-of-the-art CO2 extraction, chromatography equipment to produce THC-free distillate oil, and product manufacturing lines, we can produce over $1 billion of product per year. This is all driven by our talented, dedicated team and supported by a world-class, custom-developed, SAP-based, Cannabis ERP system that tracks the full chain of custody for every product we sell, which we believe clearly sets us apart from most other companies in the space. 22nd Century’s investment will allow us to continue to scale our business – including the acceleration of our online and retail sales and marketing efforts focused on the Panacea brand,” Buttorff explained.
“After a disciplined and thorough review of the opportunities available to 22nd Century to maximize shareholder value creation, we are pleased to announce the company’s first investment in the legal, hemp/cannabis, consumer packaged goods space,” said Cliff Fleet, Director of 22nd Century Group. “This investment is a major milestone in 22nd Century’s on-going execution of our hemp/cannabis strategic growth plan and offers the opportunity for strong projected shareholder returns.
“Our objective is to build a leading, profitable business in the emerging, legal hemp/cannabis space, and Panacea is an innovative business with a very strong management team who will be able to leverage our leadership in cannabis-plant research, our comprehensive expertise in FDA-regulated spaces, and our leadership team’s deep experience in consumer-packaged goods,” Fleet explained. “The Panacea team has an impressive track record, and I am confident Panacea is very well-positioned for the fast-growing, competitive, and increasingly complex hemp/cannabis marketplace. We are excited to be partnered with Leslie and her team,” said Michael Zercher, 22nd Century’s President and Chief Operating Officer.
The details of the Company’s investment in Panacea are described in a Form 8-K filed with the Securities and Exchange Commission.
About Panacea Life Sciences, Inc.
Panacea Life Sciences, a woman-owned and woman-led company, is dedicated to developing and producing the highest-quality, medically-relevant, legal, THC-free, hemp-derived cannabinoid products for consumers and pets from our 51,000 square foot, state-of-the-art cGMP extraction, manufacturing, testing and fulfillment center located in Golden, Colorado. Panacea operates in every segment of the CBD product value chain, from cultivation to finished goods, with stringent testing protocols employed at every stage of the supply chain from seed-to-sale. Panacea products can be purchased online at https://panacealife.com. For more information about Panacea Life Science’s history and management team visit https://panacealife.com/about/.
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on technology that allows it to decrease the level of nicotine in tobacco plants and to modify the level of cannabinoids in hemp/cannabis plants through genetic engineering and modern plant breeding. 22nd Century’s growth strategies are focused on meaningful, long-term, shareholder value creation while leveraging its strengths: leadership in cannabis plant research, comprehensive expertise in FDA-regulated spaces, a team with deep experience in consumer-packaged goods, and a strong and flexible balance sheet. To learn more about, 22nd Century please visit www.xxiicentury.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking information, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect to the contents of this press release, including but not limited to our future revenue expectations. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future results, levels of activity or performance with respect to the Company’s investment in Panacea or otherwise. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended December 31, 2018, filed on March 6, 2019, including the section entitled “Risk Factors”.
Nicholas J. Cavarra
Panacea Life Sciences, Inc.
+1 303-886-5538
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
WDDD Worlds, Inc. Wins Major USPTO Ruling
Press Release | 01/15/2020
PTAB (Patent Trial and Appeal Board) Dismisses All Remaining Inter Partes Review Proceedings Brought Against Worlds, Inc. by Bungie, Inc.
All Patent Claims Returned to Worlds, Inc.
BOSTON, MA / ACCESSWIRE / January 15, 2020 / Worlds, Inc. (OTCQB:WDDD) ("Worlds" or the "Company"), a leading intellectual property developer and licensee of patents related to 3D online virtual worlds, is pleased to announce that on January 14, 2020, the U.S. Patent Trial and Appeal Board (PTAB) issued a Notice that it has dismissed three remaining Petitions for inter partes review, filed by Bungie, Inc., against patents owned by Worlds Inc. in IPR Case Nos. 2015-01264, -01319, and -01321. The Board also vacated its prior Decisions to Institute in these cases, and terminated the inter partes review proceedings initiated by Bungie without issuing final written decisions.
Thom Kidrin, Worlds' Chief Executive Officer, commented, "We are pleased with the PTAB's decision to dismiss Bungie's remaining Petitions for inter partes review against Worlds' patents, thereby reinstating all of our claims in these cases. Worlds has had to endure the legal and financial gauntlet at the PTAB and Federal Circuit for over 4 ½ years while combating the challenges brought by Bungie, but we have ultimately prevailed with important claims intact in each challenged patent, and will return to the District Court in our case against Activision. The PTAB in the end agreed with Worlds' argument that the evidence revealed a relationship between Bungie and Activision, and that relationship prohibited Bungie from challenging Worlds' patents many years after the Activision litigation began. With Bungie's remaining petitions now dismissed, we will move forward and assert our patents against all parties that are infringing upon them."
This Notice followed from the September 7, 2018 decision of the U.S. Court of Appeals for the Federal Circuit, who previously vacated the Board's previous final written decisions in these three cases, and remanded the cases to the Board with instructions to:
consider whether Worlds is estopped from arguing the issue of Real Party in Interest ("RPI") in these proceedings, and
reevaluate the merits of Worlds' argument that Bungie is time-barred from filing petitions for inter partes review based on its relationship with Activision, who has been in litigation with Worlds on the subject patents since 2012.
The relevant statute, 35 U.S.C. § 315(b), prohibits a party from filing a petition for inter partes review more than one year after itself or an RPI was served with a complaint on the subject patent(s). Worlds argued to the Board that if Activision was an RPI to Bungie's petitions, then Bungie was not permitted to file its original petitions in 2015. As of February 22, 2019, this briefing on remand before the Board had been complete, with Worlds awaiting the Board's decision on these questions. Further, Worlds' infringement claims against Activision on these patents have been stayed pending completion of the Board's review.
The Board's Notice states that it has completed its review of the questions posed by the Federal Circuit, and determined both questions in Worlds' favor. The Board determined first that Worlds is not estopped from arguing the RPI on remand, and second that Bungie's Petitions were time-barred and must be dismissed.
The Board's Notice also states that the detailed Termination findings are currently under seal pending the identification of any confidential materials by the parties. However, a public version of the Termination document will be released no later than ten (10) business days from its issue date.
Worlds, Inc.
Worlds, Inc. (OTCQB: WDDD), is a leading intellectual property developer and licensee of patents related to 3D online virtual worlds. The Company has a portfolio of 10 US patents for multi-server technology for 3D applications. The earliest of these patents issued on an application filed November 12, 1996. A provisional patent application, serial number 60/020,296, was filed on November 13, 1995. These patents are related to each other and disclose and claim systems and methods for enabling users to interact in a virtual space.
For additional information about Worlds, Inc., please visit: www.Worlds.com.
Forward-Looking Statements
This release contains certain forward-looking statements and information relating to Worlds Inc. that are based on the beliefs of Worlds' management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "estimated," "should," "preparing," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements.
Contacts:
Accentuate PR
Julie Shepherd
847-275-3643
Julie@accentuatepr.com
Corporate
617-725-8900
info@worlds.com
SOURCE: Worlds Inc.
View source version on accesswire.com:
https://www.accesswire.com/573153/Worlds-Inc-Wins-Major-USPTO-Ruling
Knos...0022...attorney letter out today after filings hit on Wednesday....
PRED back to $1.22
Edit: Now $1.24
FCEL hit $2.95 pre market
FCEL $2.12 pre market
Followers
|
860
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
49606
|
Created
|
01/01/08
|
Type
|
Free
|
Moderator The Rainmaker | |||
Assistants budgetthis westeffer |
Rainmaker Merger Countdown Chart-Updated 12/24/10
Stage 1: This would be a dormant shell who is suddenly reactivated
Weakest one, could be a year+ before they do anything.
Also, a shell who suddenly raises their A/S or creates some new Preferred shares would be a stage 1. Still weak.
Stage 2: This would be filing a 15-12g
Still very weak, might be nothing more than someone who couldn't afford their auditor anymore, unless coupled with a name change. Or somebody who just wanted out of the expenses of being fully reporting.
Stage 3: This would be a change in officers and company address or a new website coming online.
This one is a decent place to real radar this one, maybe nibble a bit. What you want to see is the new officers have a decent track record on past business deals especially if they did a successful merger in the past.
Stage 4: would be a name change or Change of address.
(I split this stage into two groups).
A)Weaker: One's I can't find any info on new company. These I watch but don't buy.
B)Stronger: These are my favorites and where I am willing to take a chance. An exact match between the new listed address/phone and a real company who is already doing a lot of business. A company like this should be all over google. The good one's are the one's where new company name is all over google and or appears to have decent revenue. The sexier the story for the new company the more powerful.
*Now even if you make it through these four stages, Stage 5 is the make it or break it stage.
Stage 5: Final Terms and details of the merger are disclosed.
How do they structure the merger?
What percent of new company do shell holders end up with?
20-30% of new company is a dream split. 10% workable, less not usually a good deal.
Also, do they do a R/S a deal killer almost every time unless there is some interesting wrinkle or twist thrown into the deal to bring in buyers.
Bottom line until you make it to stage 5, get the answers you need regarding share structure after the merger, potential revenue going forward and get a feel whether new management is shareholder friendly....these are lotto's you throw a few dollars at hoping to get lucky. After Stage 5 you can find some life changing deals after filtering down to a few strong one's who are about to be up and running.
Posts Today
|
0
|
Posts (Total)
|
49606
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |